Drug Development and Outcome Measures in Eosinophilic Esophagitis (EoE):

Accelerate Time To Market For GI Clinical Trials

ON DEMAND WEBINAR
Duration: 1 hour‚Äč


Swallowed topical corticosteroids and proton pump inhibitors have historically been the mainstays of medical therapy for EoE. Several new classes of treatment are now in development and the therapeutic landscape is anticipated to change drastically over the next decade.

Presentations from our experts will span basic science to clinical trials covering topics including:

  • An overview of current and future therapeutic targets in EoE
  • Advancements in existing EoE drug development programs
  • The evolution in assessment of endoscopic and histologic disease activity in EoE
  • The importance of patient-reported outcomes in EoE
  • The pipeline for drug development in EoE
 

SPEAKERS

Arjan Bredenoord MD, PhD
Gastroenterologist
AMC, Amsterdam, Netherlands


Evan S. Dellon MD, MPH
Gastroenterologist
UNC-Chapel Hill, North Carolina


Ekaterina Safroneeva, PhD, PD
Senior Researcher
University of Bern, Switzerland


Christopher Ma, MD
Senior Medical Director
Alimentiv Inc.

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2023 Industry Dive | Privacy Policy | Terms of Use